Author

Jan Riemer

Primary ORCID profile (0000-0002-7574-8457 · 10 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jan RiemeriD10 papers · University of Cologne

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anna Schmitt· 1 shared Ariadne Androulidaki· 1 shared Armin Khonsari· 1 shared Christina Bebber· 1 shared Cleidson de Padua Alves· 1 shared Emily Thomas· 1 shared Fatma Parmaksiz· 1 shared Filippo BeleggiaiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna Schmitt

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes

Christina Bebber, Emily Thomas, Zhiyi Chen, Jenny Stroh, Ariadne Androulidaki, Anna Schmitt, Michaela Hoehne, Lukas Stueker, Marcel Dammert, Fatma Parmaksiz, Cleidson de Padua Alves, Armin Khonsari, Filippo Beleggia, Martin Sos, Jan Riemer, , Silvia von Karstedt

The paper identifies ferroptosis sensitivity as a distinguishing feature of non-neuroendocrine SCLC subtypes and shows that combining ferroptosis induction with TRX pathway inhibition can selectively kill both non-NE and NE SCLC tumors.

Nature Communications · Apr 6, 2021Peer-reviewedCancer Biology